Search details
1.
Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson's disease.
Brain
; 146(3): 1053-1064, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-35485491
2.
Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
Aust J Rural Health
; 32(2): 249-262, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38646861
3.
Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients.
Intern Med J
; 53(11): 2042-2049, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-36710434
4.
An integrated skin cancer education program in renal transplant recipients and patients with glomerular disease.
BMC Nephrol
; 23(1): 361, 2022 11 10.
Article
in English
| MEDLINE | ID: mdl-36357857
5.
Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson's Disease.
Int J Mol Sci
; 23(21)2022 Oct 26.
Article
in English
| MEDLINE | ID: mdl-36361716
6.
Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease.
Mov Disord
; 36(3): 611-621, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33382126
7.
Reducing non-melanoma skin cancer risk in renal transplant recipients.
Nephrology (Carlton)
; 26(11): 907-919, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34240786
8.
Comparison of skin cancer awareness and sun protection behaviours between renal transplant recipients and patients with glomerular disease treated with immunosuppressants.
Nephrology (Carlton)
; 26(4): 294-302, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-34308553
9.
Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD.
Mov Disord
; 34(11): 1690-1698, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31442355
10.
Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease.
Int J Geriatr Psychiatry
; 34(8): 1244-1250, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30993722
11.
Author reply to Gu et al. re Multidisciplinary care of skin cancer.
Intern Med J
; 54(1): 194, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38267378
12.
Intra- and inter-network functional alterations in Parkinson's disease with mild cognitive impairment.
Hum Brain Mapp
; 38(3): 1702-1715, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28084651
13.
Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 88(8): 648-652, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28250029
14.
Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
Mov Disord
; 31(1): 103-10, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26202802
15.
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
Mov Disord
; 31(7): 995-1003, 2016 07.
Article
in English
| MEDLINE | ID: mdl-26999434
16.
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Brain
; 138(Pt 10): 2974-86, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26173861
17.
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.
Brain
; 137(Pt 10): 2743-58, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25080285
18.
Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease.
Mov Disord
; 29(2): 259-62, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24464648
19.
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms.
Mov Disord
; 29(2): 195-202, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24123307
20.
Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?
Mov Disord
; 28(9): 1285-8, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23450646